Accéder au contenu
Merck

Towards a full integration of optimization and validation phases: An analytical-quality-by-design approach.

Journal of chromatography. A (2015-04-22)
C Hubert, S Houari, E Rozet, P Lebrun, Ph Hubert
RÉSUMÉ

When using an analytical method, defining an analytical target profile (ATP) focused on quantitative performance represents a key input, and this will drive the method development process. In this context, two case studies were selected in order to demonstrate the potential of a quality-by-design (QbD) strategy when applied to two specific phases of the method lifecycle: the pre-validation study and the validation step. The first case study focused on the improvement of a liquid chromatography (LC) coupled to mass spectrometry (MS) stability-indicating method by the means of the QbD concept. The design of experiments (DoE) conducted during the optimization step (i.e. determination of the qualitative design space (DS)) was performed a posteriori. Additional experiments were performed in order to simultaneously conduct the pre-validation study to assist in defining the DoE to be conducted during the formal validation step. This predicted protocol was compared to the one used during the formal validation. A second case study based on the LC/MS-MS determination of glucosamine and galactosamine in human plasma was considered in order to illustrate an innovative strategy allowing the QbD methodology to be incorporated during the validation phase. An operational space, defined by the qualitative DS, was considered during the validation process rather than a specific set of working conditions as conventionally performed. Results of all the validation parameters conventionally studied were compared to those obtained with this innovative approach for glucosamine and galactosamine. Using this strategy, qualitative and quantitative information were obtained. Consequently, an analyst using this approach would be able to select with great confidence several working conditions within the operational space rather than a given condition for the routine use of the method. This innovative strategy combines both a learning process and a thorough assessment of the risk involved.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Acide chlorhydrique solution, 1.0 N, BioReagent, suitable for cell culture
Sigma-Aldrich
Acide chlorhydrique, 36.5-38.0%, BioReagent, for molecular biology
Supelco
Acide chlorhydrique solution, volumetric, 0.1 M HCl (0.1N), endotoxin free
Sigma-Aldrich
Acétate d′ammonium, for molecular biology, ≥98%
Sigma-Aldrich
Acétate d′ammonium solution, for molecular biology, 7.5 M
Sigma-Aldrich
D-(+)-Glucosamine hydrochloride, ≥99% (HPLC), powder
Sigma-Aldrich
Ammonia, anhydrous, ≥99.98%
Sigma-Aldrich
Hydrogen chloride, ReagentPlus®, ≥99%
Sigma-Aldrich
Ammoniac solution, 4 M in methanol
Sigma-Aldrich
Ammoniac solution, 0.4 M in THF
Sigma-Aldrich
Acétate d′ammonium, 99.999% trace metals basis
Sigma-Aldrich
D-(+)-Galactosamine hydrochloride, ≥99% (HPLC)
Sigma-Aldrich
Acide chlorhydrique solution, ~6 M in H2O, for amino acid analysis
Sigma-Aldrich
Chlorure d'hydrogène solution, 3 M in cyclopentyl methyl ether (CPME)
Sigma-Aldrich
Acide chlorhydrique solution, 32 wt. % in H2O, FCC
Sigma-Aldrich
Acétate d′ammonium, reagent grade, ≥98%
Sigma-Aldrich
D-(+)-Glucosamine hydrochloride, ≥99%, BioReagent, suitable for cell culture
Sigma-Aldrich
D-(+)-Galactosamine hydrochloride, BioReagent, suitable for cell culture
Sigma-Aldrich
Acétate d′ammonium, BioXtra, ≥98%
Sigma-Aldrich
Ammonia-14N, 99.99 atom % 14N